At myotwin, we develop human heart organoids from stem cells to deliver accurate and reliable data for your drug testing and preclinical research needs. Our unique technology combines electrophysiology, calcium oscillation, and contractility measurements, providing human-relevant results that reduce the risk of costly failures in clinical trials. Partner with us to accelerate your drug development and bring safer, more effective treatments to market.